Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för C Frank Bennett. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att C Frank Bennett har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:IONS / Ionis Pharmaceuticals, Inc. | EVP, Chief Scientific Officer | 82 679 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av C Frank Bennett. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp IONS / Ionis Pharmaceuticals, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i IONS / Ionis Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i IONS / Ionis Pharmaceuticals, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av C Frank Bennett som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-09-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 000 | 82 679 | −6,77 | 59,60 | −357 581 | 4 927 404 |
2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | −12 891 | 88 679 | −12,69 | 61,50 | −792 796 | 5 453 758 |
2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −33 909 | 101 570 | −25,03 | 60,62 | −2 055 564 | 6 157 173 |
2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 46 800 | 135 479 | 52,77 | 53,77 | 2 516 436 | 7 284 706 | |
2025-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 88 679 | −5,34 | 49,14 | −245 700 | 4 357 686 |
2025-09-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 213 | 93 679 | 0,23 | 27,71 | 5 902 | 2 595 845 | |
2025-08-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 93 466 | −9,67 | 43,98 | −439 776 | 4 110 410 |
2025-08-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 10 000 | 103 466 | 10,70 | 32,60 | 326 000 | 3 372 992 | |
2025-03-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 320 | 93 466 | 0,34 | 28,21 | 9 028 | 2 636 816 | |
2025-02-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 327 | 93 146 | −1,40 | 32,46 | −43 079 | 3 023 854 | |
2025-02-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
A - Award | 3 607 | 94 473 | 3,97 | ||||
2025-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −6 752 | 90 866 | −6,92 | 32,90 | −222 114 | 2 989 128 | |
2025-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 18 011 | 97 618 | 22,62 | ||||
2024-09-04 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 885 | 79 047 | −2,33 | 49,52 | −93 337 | 3 914 060 | |
2024-09-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 177 | 79 607 | 0,22 | 38,64 | 6 839 | 3 076 094 | |
2024-03-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 383 | 79 462 | 0,48 | 34,42 | 13 185 | 2 735 479 | |
2024-02-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 853 | 79 079 | −2,29 | 49,52 | −91 752 | 3 915 644 | |
2024-02-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
A - Award | 3 609 | 80 932 | 4,67 | ||||
2024-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −6 745 | 77 323 | −8,02 | 50,42 | −340 063 | 3 898 394 | |
2024-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 18 314 | 84 068 | 27,85 | ||||
2023-12-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −16 113 | 65 754 | −19,68 | 49,29 | −794 211 | 3 241 021 | |
2023-12-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 16 113 | 81 867 | 24,50 | 47,34 | 762 789 | 3 875 584 | |
2023-12-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −6 500 | 65 754 | −9,00 | 49,64 | −322 643 | 3 263 858 | |
2023-12-22 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 500 | 72 254 | 9,89 | 47,34 | 307 710 | 3 420 504 | |
2023-12-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −8 610 | 65 754 | −11,58 | 50,19 | −432 110 | 3 299 996 | |
2023-12-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 8 610 | 74 364 | 13,09 | 47,34 | 407 597 | 3 520 392 | |
2023-12-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −14 002 | 65 754 | −17,56 | 49,21 | −689 085 | 3 235 971 | |
2023-12-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 14 002 | 79 756 | 21,29 | 47,34 | 662 855 | 3 775 649 | |
2023-09-29 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 460 | 65 754 | −6,35 | 46,50 | −207 390 | 3 057 561 |
2023-09-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 180 | 70 214 | 0,26 | 30,56 | 5 500 | 2 145 564 | |
2023-03-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 383 | 70 034 | 0,55 | 30,52 | 11 687 | 2 137 088 | |
2023-02-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −1 813 | 69 651 | −2,54 | 40,57 | −73 560 | 2 826 006 | |
2023-02-07 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
A - Award | 3 609 | 71 464 | 5,32 | ||||
2023-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −6 978 | 67 855 | −9,32 | 38,89 | −271 356 | 2 638 705 | |
2023-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 19 417 | 74 833 | 35,04 | ||||
2022-09-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 183 | 55 416 | 0,33 | 28,97 | 5 301 | 1 605 291 | |
2022-03-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 346 | 55 233 | 0,63 | 28,37 | 9 817 | 1 567 126 | |
2022-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Unit |
M - Exercise | −18 842 | 24 444 | −43,53 | ||||
2022-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −6 726 | 54 887 | −10,92 | 30,12 | −202 587 | 1 653 196 | |
2022-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 18 842 | 61 613 | 44,05 | ||||
2022-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Unit |
A - Award | 14 435 | 43 286 | 50,03 | ||||
2022-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Performance Restricted Stock Units |
A - Award | 10 826 | 10 826 | |||||
2022-01-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Non-Qualified Stock Option (right to buy) |
A - Award | 28 869 | 28 869 | |||||
2021-09-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 151 | 42 771 | 0,35 | 33,80 | 5 103 | 1 445 489 | |
2021-03-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 112 | 42 620 | 0,26 | 44,54 | 4 988 | 1 898 295 | |
2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −15 520 | 29 641 | −34,37 | ||||
2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 20 822 | 20 822 | |||||
2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −5 488 | 42 508 | −11,43 | 61,28 | −336 305 | 2 604 890 | |
2021-01-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 15 520 | 47 996 | 47,79 | ||||
2021-01-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 46 850 | 46 850 | |||||
2020-12-08 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −7 947 | 0 | −100,00 | ||||
2020-12-08 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 947 | 32 476 | −19,66 | 51,04 | −405 615 | 1 657 575 |
2020-12-08 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 7 947 | 40 423 | 24,47 | 39,87 | 316 847 | 1 611 665 |
2020-12-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −7 053 | 7 947 | −47,02 | ||||
2020-12-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 053 | 32 476 | −17,84 | 51,32 | −361 960 | 1 666 668 |
2020-12-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 7 053 | 39 529 | 21,72 | 39,87 | 281 203 | 1 576 021 |
2020-11-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −15 000 | 15 000 | −50,00 | ||||
2020-11-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −15 000 | 32 476 | −31,59 | 46,77 | −701 600 | 1 519 010 |
2020-11-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 15 000 | 47 476 | 46,19 | 39,87 | 598 050 | 1 892 868 |
2020-09-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 112 | 32 476 | 0,35 | 44,46 | 4 979 | 1 443 721 | |
2020-06-29 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −15 000 | 32 364 | −31,67 | 59,77 | −896 505 | 1 934 299 |
2020-06-29 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 15 000 | 47 364 | 46,35 | 39,87 | 598 050 | 1 888 403 |
2020-03-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 169 | 32 364 | 0,52 | 43,16 | 7 295 | 1 396 927 | |
2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −11 711 | 23 549 | −33,21 | ||||
2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 21 612 | 21 612 | |||||
2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −4 162 | 32 195 | −11,45 | 62,06 | −258 294 | 1 998 022 | |
2020-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 11 711 | 36 357 | 47,52 | ||||
2020-01-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 48 626 | 48 626 | |||||
2019-07-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 118 | 24 646 | 0,48 | 45,70 | 5 393 | 1 126 433 | |
2019-02-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 9 013 | 0 | −100,00 | ||||
2019-02-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −9 013 | 24 528 | −26,87 | 58,29 | −525 368 | 1 429 737 |
2019-02-05 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 9 013 | 33 541 | 36,75 | 14,69 | 132 401 | 492 717 |
2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −7 822 | 14 463 | −35,10 | ||||
2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 20 797 | 20 797 | |||||
2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
F - Taxes | −2 818 | 24 400 | −10,35 | 58,26 | −164 177 | 1 421 544 | |
2019-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 7 822 | 27 218 | 40,33 | ||||
2019-01-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 46 800 | 46 800 | |||||
2019-01-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 128 | 19 524 | 0,66 | 36,45 | 4 665 | 711 611 | |
2018-11-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 12 500 | 9 013 | −358,47 | ||||
2018-11-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 500 | 19 396 | −39,19 | 49,54 | −619 245 | 960 870 |
2018-11-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 500 | 31 896 | 64,45 | 14,69 | 183 625 | 468 552 |
2018-08-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 12 487 | 21 513 | 138,34 | ||||
2018-08-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 13 | 0 | −100,00 | ||||
2018-08-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 487 | 19 396 | −39,17 | 45,00 | −561 915 | 872 820 |
2018-08-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 487 | 31 883 | 64,38 | 14,69 | 183 434 | 468 361 |
2018-08-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −13 | 19 396 | −0,07 | 45,00 | −585 | 872 820 |
2018-08-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 13 | 19 409 | 0,07 | 7,25 | 94 | 140 715 |
2018-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 282 | 19 396 | 1,48 | 35,42 | 9 988 | 686 997 | |
2018-05-11 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 12 500 | 13 | −100,10 | ||||
2018-05-11 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 500 | 19 114 | −39,54 | 45,00 | −562 500 | 860 130 |
2018-05-11 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 500 | 31 614 | 65,40 | 7,25 | 90 625 | 229 202 |
2018-02-01 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | 12 500 | 12 513 | 96 153,85 | ||||
2018-02-01 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 500 | 19 114 | −39,54 | 52,50 | −656 260 | 1 003 500 |
2018-02-01 |
|
4/A | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 500 | 31 614 | 65,40 | 7,25 | 90 625 | 229 202 |
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 696 | 19 114 | −12,36 | 51,76 | −139 545 | 989 341 | |
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −6 663 | 10 148 | −39,63 | ||||
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 12 137 | 12 137 | |||||
2018-01-17 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 663 | 21 810 | 43,99 | ||||
2018-01-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 54 619 | 54 619 | |||||
2018-01-02 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 106 | 15 147 | 0,70 | 42,76 | 4 532 | 647 610 | |
2017-10-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −12 250 | 0 | −100,00 | ||||
2017-10-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 250 | 15 041 | −44,89 | 65,00 | −796 250 | 977 665 |
2017-10-20 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 250 | 27 291 | 81,44 | 10,29 | 126 052 | 280 824 |
2017-07-26 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 12 250 | −44,94 | ||||
2017-07-26 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 15 041 | −39,93 | 59,29 | −592 900 | 891 781 |
2017-07-26 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 25 041 | 66,48 | 10,29 | 102 900 | 257 672 |
2017-07-03 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 253 | 15 041 | 1,71 | 40,66 | 10 286 | 611 499 | |
2017-03-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 22 250 | −18,35 | ||||
2017-03-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 14 788 | −25,27 | 55,00 | −275 000 | 813 340 |
2017-03-06 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 19 788 | 33,81 | 10,29 | 51 450 | 203 619 |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −623 | 14 788 | −4,04 | 46,29 | −28 839 | 684 537 | |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −512 | 13 817 | −3,57 | 46,29 | −23 701 | 639 603 | |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −733 | 13 018 | −5,33 | 46,29 | −33 931 | 602 603 | |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −553 | 11 876 | −4,45 | 46,29 | −25 598 | 549 740 | |
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 594 | 4 779 | −25,01 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 311 | 2 620 | −33,35 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 875 | 1 875 | −50,00 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 415 | 0 | −100,00 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 7 537 | 7 537 | |||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 594 | 15 411 | 11,54 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 311 | 14 329 | 10,07 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 875 | 13 751 | 15,79 | ||||
2017-01-18 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 415 | 12 429 | 12,85 | ||||
2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 45 225 | 45 225 | |||||
2017-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 211 | 11 014 | 1,95 | 20,76 | 4 380 | 228 618 | |
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −22 805 | 0 | −100,00 | ||||
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −17 805 | 10 803 | −62,24 | 38,54 | −686 205 | 416 348 |
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 17 805 | 28 608 | 164,82 | 11,27 | 200 662 | 322 412 |
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 10 803 | −31,64 | 34,08 | −170 400 | 368 166 |
2016-11-14 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 15 803 | 46,28 | 11,27 | 56 350 | 178 100 |
2016-11-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 22 805 | −17,98 | ||||
2016-11-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 10 803 | −31,64 | 34,00 | −170 000 | 367 302 |
2016-11-09 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 15 803 | 46,28 | 11,27 | 56 350 | 178 100 |
2016-07-01 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 213 | 10 803 | 2,01 | 20,76 | 4 421 | 224 238 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −522 | 10 590 | −4,70 | 41,46 | −21 640 | 439 021 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −747 | 9 801 | −7,08 | 41,46 | −30 967 | 406 305 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −564 | 8 673 | −6,11 | 41,46 | −23 383 | 359 572 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −277 | 7 822 | −3,42 | 41,46 | −11 484 | 324 284 | |
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 311 | 3 931 | −25,01 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 875 | 3 750 | −33,33 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 415 | 1 415 | −50,00 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −694 | 0 | −100,00 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 6 373 | 6 373 | |||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 311 | 11 112 | 13,38 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 875 | 10 548 | 21,62 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 415 | 9 237 | 18,09 | ||||
2016-01-19 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 694 | 8 099 | 9,37 | ||||
2016-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 38 240 | 38 240 | |||||
2016-01-04 |
|
4 | IONS |
IONIS PHARMACEUTICALS INC
Common Stock |
J - Other | 89 | 7 405 | 1,22 | 47,71 | 4 246 | 353 296 | |
2015-12-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −3 909 | 0 | −100,00 | ||||
2015-12-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 909 | 7 316 | −34,82 | 58,85 | −230 045 | 430 547 |
2015-12-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 909 | 11 225 | 53,43 | 14,47 | 56 563 | 162 426 |
2015-12-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −4 000 | 3 909 | −50,58 | ||||
2015-12-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 000 | 7 316 | −35,35 | 56,00 | −224 000 | 409 696 |
2015-12-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 000 | 11 316 | 54,67 | 14,47 | 57 880 | 163 743 |
2015-11-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 7 909 | −38,73 | ||||
2015-11-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 7 316 | −40,60 | 64,00 | −320 000 | 468 224 |
2015-11-12 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 12 316 | 68,34 | 14,47 | 72 350 | 178 213 |
2015-11-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 12 909 | −27,92 | ||||
2015-11-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 7 316 | −40,60 | 56,00 | −280 000 | 409 696 |
2015-11-09 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 12 316 | 68,34 | 14,47 | 72 350 | 178 213 |
2015-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 87 | 7 316 | 1,20 | 48,59 | 4 227 | 355 455 | |
2015-03-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −9 000 | 17 909 | −33,45 | ||||
2015-03-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −9 000 | 7 229 | −55,46 | 71,01 | −639 090 | 513 331 |
2015-03-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 9 000 | 16 229 | 124,50 | 14,47 | 130 230 | 234 834 |
2015-03-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −6 000 | 26 909 | −18,23 | ||||
2015-03-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 7 229 | −12,15 | 71,00 | −71 000 | 513 259 |
2015-03-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 8 229 | 13,83 | 14,47 | 14 470 | 119 074 |
2015-03-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 7 229 | −40,89 | 69,80 | −349 020 | 504 613 |
2015-03-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 12 229 | 69,17 | 14,47 | 72 350 | 176 954 |
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −714 | 7 229 | −8,99 | 67,96 | −48 526 | 491 312 | |
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −539 | 6 068 | −8,16 | 67,96 | −36 633 | 412 406 | |
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −265 | 5 192 | −4,86 | 67,96 | −18 010 | 352 869 | |
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 875 | 5 625 | −25,00 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 415 | 2 830 | −33,33 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −694 | 694 | −50,00 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 5 242 | 5 242 | |||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 875 | 7 943 | 30,90 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 415 | 6 607 | 27,25 | ||||
2015-01-20 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 694 | 5 457 | 14,57 | ||||
2015-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 31 457 | 31 457 | |||||
2015-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 136 | 4 763 | 2,94 | 30,05 | 4 086 | 143 116 | |
2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 0 | −100,00 | ||||
2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 4 627 | −30,18 | 40,55 | −81 100 | 187 625 |
2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 6 627 | 43,22 | 15,38 | 30 760 | 101 923 |
2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 000 | 6 627 | 43,22 | 15,38 | 30 760 | 101 923 |
2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 000 | 4 627 | −17,77 | 40,53 | −40 530 | 187 532 |
2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 000 | 5 627 | 21,61 | 15,38 | 15 380 | 86 543 |
2014-08-28 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 000 | 4 627 | −30,18 | 40,50 | −81 000 | 187 394 |
2014-07-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 291 | 4 627 | 6,71 | 30,20 | 8 788 | 139 738 | |
2014-06-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −11 200 | 5 000 | −69,14 | ||||
2014-06-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 4 336 | −53,56 | 36,54 | −182 715 | 158 450 |
2014-06-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 9 336 | 115,31 | 15,38 | 76 900 | 143 588 |
2014-06-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 200 | 4 336 | −58,85 | 36,97 | −229 195 | 160 289 |
2014-06-25 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 200 | 10 536 | 142,99 | 15,38 | 95 356 | 162 044 |
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −265 | 4 336 | −5,76 | 47,08 | −12 476 | 204 143 | |
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −539 | 3 906 | −12,13 | 47,08 | −25 377 | 183 899 | |
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −695 | 1 388 | −33,37 | ||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −1 415 | 4 245 | −25,00 | ||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 7 500 | 7 500 | |||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 695 | 4 601 | 17,79 | ||||
2014-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 1 415 | 4 445 | 46,70 | ||||
2014-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 45 000 | 45 000 | |||||
2014-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 164 | 3 030 | 5,72 | 24,20 | 3 969 | 73 324 | |
2013-12-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 16 200 | −38,17 | ||||
2013-12-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 550 | 2 866 | −61,35 | 39,90 | −181 545 | 114 353 |
2013-12-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 550 | 7 416 | 158,76 | 15,38 | 69 979 | 114 058 |
2013-12-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 640 | 2 866 | −55,95 | 39,94 | −145 382 | 114 468 |
2013-12-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 3 640 | 6 506 | 127,01 | 15,38 | 55 983 | 100 062 |
2013-12-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 810 | 2 866 | −38,71 | 39,92 | −72 255 | 114 411 |
2013-12-06 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 1 810 | 4 676 | 63,15 | 15,38 | 27 838 | 71 917 |
2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 26 200 | −27,62 | ||||
2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 2 866 | −77,72 | 35,02 | −350 200 | 100 367 |
2013-09-23 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 12 866 | 348,92 | 15,38 | 153 800 | 197 879 |
2013-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −10 000 | 36 200 | −21,65 | ||||
2013-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 2 866 | −77,72 | 30,22 | −302 250 | 86 625 |
2013-09-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 10 000 | 12 866 | 348,92 | 15,38 | 153 800 | 197 879 |
2013-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 756 | 2 866 | 35,83 | 9,20 | 6 953 | 26 359 | |
2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −6 145 | 0 | −100,00 | ||||
2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −23 800 | 0 | −100,00 | ||||
2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 145 | 2 110 | −74,44 | 22,26 | −136 794 | 46 971 |
2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 145 | 8 255 | 291,23 | 11,12 | 68 332 | 91 796 |
2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −23 800 | 2 110 | −91,86 | 22,26 | −529 812 | 46 971 |
2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 23 800 | 25 910 | 1 127,96 | 6,81 | 162 078 | 176 447 |
2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −30 000 | 6 145 | −83,00 | ||||
2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −30 000 | 2 110 | −93,43 | 22,51 | −675 153 | 47 486 |
2013-05-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 30 000 | 32 110 | 1 421,80 | 11,12 | 333 600 | 357 063 |
2013-02-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 34 000 | 34 000 | |||||
2013-02-01 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 5 660 | 5 660 | |||||
2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | −309 | 2 110 | −12,77 | 14,00 | −4 326 | 29 540 | |
2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −695 | 2 083 | −25,02 | ||||
2013-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 695 | 2 419 | 40,31 | ||||
2013-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 447 | 1 724 | 35,00 | 8,87 | 3 967 | 15 299 | |
2012-07-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 000 | 23 800 | −17,36 | ||||
2012-07-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −5 500 | 0 | −100,00 | ||||
2012-07-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 000 | 1 277 | −79,66 | 13,51 | −67 550 | 17 252 |
2012-07-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 000 | 6 277 | 391,54 | 6,81 | 34 050 | 42 746 |
2012-07-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 500 | 1 277 | −81,16 | 13,51 | −74 305 | 17 252 |
2012-07-11 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 500 | 6 777 | 430,70 | 6,84 | 37 620 | 46 355 |
2012-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
M - Exercise | −6 000 | 5 500 | −52,17 | ||||
2012-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 000 | 1 277 | −82,45 | 12,91 | −77 460 | 16 486 |
2012-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 6 000 | 7 277 | 469,85 | 6,84 | 41 040 | 49 775 |
2012-07-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 648 | 1 277 | 103,02 | 6,13 | 3 971 | 7 826 | |
2012-03-07 |
|
4/A | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 25 013 | 25 013 | |||||
2012-03-07 |
|
4/A | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 324 | 629 | 106,23 | 6,13 | 1 986 | 3 855 | |
2012-01-17 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 2 778 | 2 778 | |||||
2012-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 25 013 | 25 013 | |||||
2012-01-03 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 324 | 629 | 106,23 | 6,13 | 1 986 | 3 855 | |
2010-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Employee Stock Option (right to buy) |
A - Award | 27 805 | 27 805 | |||||
2010-01-05 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 195 | 1 171 | 19,98 | 9,44 | 1 841 | 11 058 | |
2004-07-02 |
|
4 | ISIS |
ISIS PHARMACEUTICALS INC
Common Stock |
J - Other | 295 | 858 | 52,40 | 4,86 | 1 434 | 4 172 |